Amanote Research
Register
Sign In
Pembro Ups Survival in PD-L1–positive HNSCC
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2018-151
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
November 8, 2018
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
PD-L1 Inhibitor Improves Survival in TNBC
Cancer Discovery
Oncology
Atezolizumab Combo Approved for PD-L1–positive TNBC
Cancer Discovery
Oncology
NSCLC: Zwei Positive Studien Zu PD-L1-Hemmer
Im Focus Onkologie
PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
Combined Radiation and PD-L1 Blockade Improved Tumor Control in Mouse Head and Neck Squamous Cell Carcinoma (HNSCC)
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Macrophage PD-L1 Strikes Back: PD-1/PD-L1 Interaction Drives Macrophages Toward Regulatory Subsets
Advances in Bioscience and Biotechnology
Immune Profiling of Malignant Pleural Mesothelioma by Flow Cytometry Identifies Distinct T-Cell Activation and Exhaustion Phenotypes in PD-L1 Positive Versus PD-L1 Negative Tumors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Long-Term Survival in Patients Responding to Anti-Pd-1/Pd-L1 Therapy and Disease Outcome Upon Treatment Discontinuation
Clinical Cancer Research
Cancer Research
Oncology
ARID1A Alterations Function as a Biomarker for Longer Progression-Free Survival After Anti-Pd-1/Pd-L1 Immunotherapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
